Compass Wealth Management LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 11,026 shares of the company’s stock, valued at approximately $4,299,000.
A number of other large investors have also made changes to their positions in the company. Nomura Asset Management Co. Ltd. increased its position in shares of HCA Healthcare by 6.2% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after acquiring an additional 3,724 shares in the last quarter. Advisors Capital Management LLC increased its position in shares of HCA Healthcare by 61.5% in the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after acquiring an additional 2,604 shares during the last quarter. Liberty Wealth Management LLC acquired a new stake in shares of HCA Healthcare in the 4th quarter valued at approximately $1,905,000. Arrowstreet Capital Limited Partnership grew its position in shares of HCA Healthcare by 11.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock valued at $1,078,966,000 after acquiring an additional 245,887 shares during the period. Finally, Sunbelt Securities Inc. grew its holdings in HCA Healthcare by 171.7% during the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock worth $2,954,000 after purchasing an additional 3,945 shares during the period. Institutional investors own 62.73% of the company’s stock.
Analysts Set New Price Targets
A number of analysts have recently issued reports on HCA shares. Deutsche Bank Aktiengesellschaft set a $476.00 target price on shares of HCA Healthcare in a research note on Monday, July 27th. Barclays lowered their target price on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a report on Monday, July 27th. Robert W. Baird reduced their target price on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a report on Monday, July 27th. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Finally, Argus cut their target price on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $465.59.
HCA Healthcare Stock Performance
HCA Healthcare stock opened at $412.27 on Wednesday. The firm’s 50-day simple moving average is $395.07 and its 200 day simple moving average is $445.35. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The stock has a market cap of $89.26 billion, a PE ratio of 13.80, a price-to-earnings-growth ratio of 1.40 and a beta of 1.10.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.84 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.
HCA Healthcare Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is presently 10.45%.
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
